117 related articles for article (PubMed ID: 228124)
1. Effect of metyrapone and aminoglutethimide on the murine sarcoma (MuSV-M) and breast adenocarcinoma (C3HBA).
Seifter E; Critselis AN; Levenson SM; Rettura G
J Surg Oncol; 1979; 12(3):281-8. PubMed ID: 228124
[No Abstract] [Full Text] [Related]
2. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
Thorén M; Adamson U; Sjöberg HE
Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor growth by metyrapone and desoxycorticosterone.
Rettura G; Sarkar D; Padawer J; Levenson SM; Seifter E
Surg Forum; 1976; 27(62):153-4. PubMed ID: 1019837
[No Abstract] [Full Text] [Related]
4. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
[TBL] [Abstract][Full Text] [Related]
5. [Estrogenic and antineoplastic activity of a series of transformed analogs of estrone and estradiol].
Sorokina IB; Barkova TI; Zakharychev AA; Chigir' RN; Ananchenko SN
Izv Akad Nauk SSSR Biol; 1973; 5():664-70. PubMed ID: 4761310
[No Abstract] [Full Text] [Related]
6. [Studies on the effect of a new verucarin E analog WER I on the growth of experimental neoplasms].
Nowak HF; Jodczyk KJ; Zimnoch L; Duda D; Piotrowska-Olczak H; Rózański A
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1980; 25():175-95. PubMed ID: 6797024
[No Abstract] [Full Text] [Related]
7. Combined treatment with radioestradiol-lucanthone in mouse C3HBA mammary adenocarcinoma and with estradiol-lucanthone in an estrogen bioassay.
Padawer J; Rettura G; Thysen B; Gatz M; Seifter E
Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):349-57. PubMed ID: 7275712
[No Abstract] [Full Text] [Related]
8. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
[TBL] [Abstract][Full Text] [Related]
9. Anticancer properties of isoniazid & hydrazine-sulphate.
Bhide SV
Indian J Exp Biol; 1978 Aug; 16(8):926-8. PubMed ID: 711258
[No Abstract] [Full Text] [Related]
10. Successful long-term coumadin anticoagulation of mice with prothrombin time monitoring.
Ryan JJ; Orme SK; Wexler H; Ketcham AS
J Surg Oncol; 1969; 1(2):115-21. PubMed ID: 5406360
[No Abstract] [Full Text] [Related]
11. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
Zimel H
Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
[No Abstract] [Full Text] [Related]
12. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
Mihich E; Gelzer J
Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
[No Abstract] [Full Text] [Related]
13. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
Maral R; Bourat G; Ducrot R; Fournel J; Ganter P; Julou L; Koenig F; Myon J; Pascal S; Pasquet J; Populaire P; de Ratuld Y; Werner GH
Pathol Biol; 1967 Oct; 15(19):903-8. PubMed ID: 4296784
[No Abstract] [Full Text] [Related]
14. Theoretical basis for response to steroid suppression in major depression.
Rothschild AJ; Schatzberg AF
J Clin Psychopharmacol; 1992 Apr; 12(2):142-4. PubMed ID: 1573041
[No Abstract] [Full Text] [Related]
15. Apoptosis in murine tumors treated with chemotherapy agents.
Meyn RE; Stephens LC; Hunter NR; Milas L
Anticancer Drugs; 1995 Jun; 6(3):443-50. PubMed ID: 7670143
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
[TBL] [Abstract][Full Text] [Related]
17. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
Bissery MC; Guénard D; Guéritte-Voegelein F; Lavelle F
Cancer Res; 1991 Sep; 51(18):4845-52. PubMed ID: 1680023
[TBL] [Abstract][Full Text] [Related]
18. Concepts for controlling drug-resistant tumor cells.
Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
[No Abstract] [Full Text] [Related]
19. Effect of estrogen and antiestrogen therapy in rats bearing mesenchymal tumors.
Remedi MM; Demarchi M; Hliba E; Depiante-Depaoli M
Tumour Biol; 1999; 20(5):242-50. PubMed ID: 10436416
[TBL] [Abstract][Full Text] [Related]
20. Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies.
Aguirre G; Boiani M; Cerecetto H; Fernández M; González M; León E; Pintos C; Raymondo S; Arredondo C; Pacheco JP; Basombrío MA
Pharmazie; 2006 Jan; 61(1):54-9. PubMed ID: 16454207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
